Bullnet Capital

FYLA Laser S.L., established in 2006 and headquartered in Valencia, Spain, specializes in the manufacture of advanced laser technologies. The company produces a range of fiber lasers, including white in-fiber lasers, soft pulse in-fiber lasers, cold pulse in-fiber lasers, and supercontinuum lasers, as well as ultrafast pulsed lasers and accessory modules. These products cater to various industries, with notable applications in materials processing, bio-imaging, and industrial metrology. FYLA aims to lead industry transformation by leveraging photonics to develop new sectors and applications, while focusing on quality and profitability for its clients. The organization emphasizes the importance of technology, skilled personnel, and core values in driving innovation and expanding its client base across life sciences, materials processing, and optical communications.

Wooptix S.L., founded in 2014 and headquartered in Madrid, Spain, specializes in advanced imaging technologies. The company develops light field and wavefront phase imaging software that captures comprehensive information about light, utilizing the full resolution of sensors. This innovative platform allows for three-dimensional modulation of images across various camera setups, producing volumetric images and videos with enhanced data points and high frame rates. By focusing on improving human interaction with the environment, Wooptix aims to redefine the way users perceive and engage with their surroundings, offering new possibilities for image quality and post-processing capabilities.

Quside is a Barcelona-based startup that designs and manufactures innovative quantum components for any connected device. Using their proprietary quantum random number generation technology, they are enabling the next generation of encryption solutions.

2Eyes Vision S.L, founded in 2015 and based in Madrid, Spain, specializes in developing technology for visual diagnostics and corrections. The company has created SimVis, a proprietary visual simulation technology specifically designed for multifocal lens applications in presbyopia and cataract surgery. This technology allows patients to experience real-world vision prior to undergoing surgical procedures, addressing the challenge faced by surgeons in selecting the most suitable intraocular lenses from a vast array of options available in the market. The SimVis Gekko device, which has received FDA clearance and CE marking, is portable and user-friendly, enhancing patient satisfaction and assisting ophthalmologists in making informed decisions about lens selection. With over 2 billion people globally affected by presbyopia and cataracts, and an aging population contributing to increased surgical options, 2Eyes Vision aims to improve clinical practices and patient outcomes in the field of ophthalmology.

Quside is a Barcelona-based startup that designs and manufactures innovative quantum components for any connected device. Using their proprietary quantum random number generation technology, they are enabling the next generation of encryption solutions.

FYLA Laser S.L., established in 2006 and headquartered in Valencia, Spain, specializes in the manufacture of advanced laser technologies. The company produces a range of fiber lasers, including white in-fiber lasers, soft pulse in-fiber lasers, cold pulse in-fiber lasers, and supercontinuum lasers, as well as ultrafast pulsed lasers and accessory modules. These products cater to various industries, with notable applications in materials processing, bio-imaging, and industrial metrology. FYLA aims to lead industry transformation by leveraging photonics to develop new sectors and applications, while focusing on quality and profitability for its clients. The organization emphasizes the importance of technology, skilled personnel, and core values in driving innovation and expanding its client base across life sciences, materials processing, and optical communications.

2Eyes Vision S.L, founded in 2015 and based in Madrid, Spain, specializes in developing technology for visual diagnostics and corrections. The company has created SimVis, a proprietary visual simulation technology specifically designed for multifocal lens applications in presbyopia and cataract surgery. This technology allows patients to experience real-world vision prior to undergoing surgical procedures, addressing the challenge faced by surgeons in selecting the most suitable intraocular lenses from a vast array of options available in the market. The SimVis Gekko device, which has received FDA clearance and CE marking, is portable and user-friendly, enhancing patient satisfaction and assisting ophthalmologists in making informed decisions about lens selection. With over 2 billion people globally affected by presbyopia and cataracts, and an aging population contributing to increased surgical options, 2Eyes Vision aims to improve clinical practices and patient outcomes in the field of ophthalmology.

2Eyes Vision S.L, founded in 2015 and based in Madrid, Spain, specializes in developing technology for visual diagnostics and corrections. The company has created SimVis, a proprietary visual simulation technology specifically designed for multifocal lens applications in presbyopia and cataract surgery. This technology allows patients to experience real-world vision prior to undergoing surgical procedures, addressing the challenge faced by surgeons in selecting the most suitable intraocular lenses from a vast array of options available in the market. The SimVis Gekko device, which has received FDA clearance and CE marking, is portable and user-friendly, enhancing patient satisfaction and assisting ophthalmologists in making informed decisions about lens selection. With over 2 billion people globally affected by presbyopia and cataracts, and an aging population contributing to increased surgical options, 2Eyes Vision aims to improve clinical practices and patient outcomes in the field of ophthalmology.

FYLA Laser S.L., established in 2006 and headquartered in Valencia, Spain, specializes in the manufacture of advanced laser technologies. The company produces a range of fiber lasers, including white in-fiber lasers, soft pulse in-fiber lasers, cold pulse in-fiber lasers, and supercontinuum lasers, as well as ultrafast pulsed lasers and accessory modules. These products cater to various industries, with notable applications in materials processing, bio-imaging, and industrial metrology. FYLA aims to lead industry transformation by leveraging photonics to develop new sectors and applications, while focusing on quality and profitability for its clients. The organization emphasizes the importance of technology, skilled personnel, and core values in driving innovation and expanding its client base across life sciences, materials processing, and optical communications.

FYLA Laser S.L., established in 2006 and headquartered in Valencia, Spain, specializes in the manufacture of advanced laser technologies. The company produces a range of fiber lasers, including white in-fiber lasers, soft pulse in-fiber lasers, cold pulse in-fiber lasers, and supercontinuum lasers, as well as ultrafast pulsed lasers and accessory modules. These products cater to various industries, with notable applications in materials processing, bio-imaging, and industrial metrology. FYLA aims to lead industry transformation by leveraging photonics to develop new sectors and applications, while focusing on quality and profitability for its clients. The organization emphasizes the importance of technology, skilled personnel, and core values in driving innovation and expanding its client base across life sciences, materials processing, and optical communications.

KDPOF is a Madrid-based company specializing in high-capacity communication technology using Large Core Plastic Optical Fiber (POF). The company develops advanced systems that include digital integrated circuits designed for robust optical networking, particularly suited for harsh environments and long-reach communications. KDPOF's products are characterized by their inherent galvanic isolation, lightweight design, and cost-effectiveness. These features enable home and small office/home office (SOHO) networks, as well as clients in the automotive and industrial sectors, to achieve optical gigabit connectivity tailored to their specific needs. Through its innovative approach, KDPOF aims to enhance the efficiency and adaptability of POF communication technology, leveraging the latest advancements in digital communications and information theory.

2Eyes Vision S.L, founded in 2015 and based in Madrid, Spain, specializes in developing technology for visual diagnostics and corrections. The company has created SimVis, a proprietary visual simulation technology specifically designed for multifocal lens applications in presbyopia and cataract surgery. This technology allows patients to experience real-world vision prior to undergoing surgical procedures, addressing the challenge faced by surgeons in selecting the most suitable intraocular lenses from a vast array of options available in the market. The SimVis Gekko device, which has received FDA clearance and CE marking, is portable and user-friendly, enhancing patient satisfaction and assisting ophthalmologists in making informed decisions about lens selection. With over 2 billion people globally affected by presbyopia and cataracts, and an aging population contributing to increased surgical options, 2Eyes Vision aims to improve clinical practices and patient outcomes in the field of ophthalmology.

FYLA Laser S.L., established in 2006 and headquartered in Valencia, Spain, specializes in the manufacture of advanced laser technologies. The company produces a range of fiber lasers, including white in-fiber lasers, soft pulse in-fiber lasers, cold pulse in-fiber lasers, and supercontinuum lasers, as well as ultrafast pulsed lasers and accessory modules. These products cater to various industries, with notable applications in materials processing, bio-imaging, and industrial metrology. FYLA aims to lead industry transformation by leveraging photonics to develop new sectors and applications, while focusing on quality and profitability for its clients. The organization emphasizes the importance of technology, skilled personnel, and core values in driving innovation and expanding its client base across life sciences, materials processing, and optical communications.

2Eyes Vision S.L, founded in 2015 and based in Madrid, Spain, specializes in developing technology for visual diagnostics and corrections. The company has created SimVis, a proprietary visual simulation technology specifically designed for multifocal lens applications in presbyopia and cataract surgery. This technology allows patients to experience real-world vision prior to undergoing surgical procedures, addressing the challenge faced by surgeons in selecting the most suitable intraocular lenses from a vast array of options available in the market. The SimVis Gekko device, which has received FDA clearance and CE marking, is portable and user-friendly, enhancing patient satisfaction and assisting ophthalmologists in making informed decisions about lens selection. With over 2 billion people globally affected by presbyopia and cataracts, and an aging population contributing to increased surgical options, 2Eyes Vision aims to improve clinical practices and patient outcomes in the field of ophthalmology.

Wooptix S.L., founded in 2014 and headquartered in Madrid, Spain, specializes in advanced imaging technologies. The company develops light field and wavefront phase imaging software that captures comprehensive information about light, utilizing the full resolution of sensors. This innovative platform allows for three-dimensional modulation of images across various camera setups, producing volumetric images and videos with enhanced data points and high frame rates. By focusing on improving human interaction with the environment, Wooptix aims to redefine the way users perceive and engage with their surroundings, offering new possibilities for image quality and post-processing capabilities.

KDPOF is a Madrid-based company specializing in high-capacity communication technology using Large Core Plastic Optical Fiber (POF). The company develops advanced systems that include digital integrated circuits designed for robust optical networking, particularly suited for harsh environments and long-reach communications. KDPOF's products are characterized by their inherent galvanic isolation, lightweight design, and cost-effectiveness. These features enable home and small office/home office (SOHO) networks, as well as clients in the automotive and industrial sectors, to achieve optical gigabit connectivity tailored to their specific needs. Through its innovative approach, KDPOF aims to enhance the efficiency and adaptability of POF communication technology, leveraging the latest advancements in digital communications and information theory.

Oncovision (GEM Imaging S.A.) is a Spanish technologic start-up company created in 2003 with the initiative of the Corpuscular Physics Institute (CSIC) and the University of Valencia. They work in Molecular Vision applied to Health Sciences focusing in: cancer diagnosis and treatment, and advanced research in neurology, oncology, and cardiology. They are a company focused on Molecular Vision, which creates, develops and markets new medical technologies, global innovations with relevant clinical and economic advantages, often representing a breakthrough in current standards of diagnosis and treatment. ONCOVISION´s original, fresh technology, strong intellectual property, top-level clinical evidence, leading global reference centers, and pioneering protocols, is supported by its dynamic cross-functional team. ONCOVISION is opening unprecedented options in the treatment of cancer and serious cardiac and neurological diseases. Their team and the company’s technologies have been recognized by Spanish and European prestigious institutions. In 2007, the company was selected as one of the “20 Best Technologic Companies in Spain” and won the “National Medical Physics 2007 Congress Award” In 2008, it was one of the “20 Best Health Technology Companies in Europe” by the prestigious European Technology Tour, as well as finalist in the “National 25th Aniversary Enisa Award” Prof. Jose María Benlloch, active member of the company, won in 2008, the well-known “Jaime I” award. Scientists, technicians, and technologists of ONCOVISION have dozens of publications and presentations at scientific and medical conferences worldwide. Their shareholding, based in Valencia, was strengthened in August 2006 by the Spanish venture capital firm Bullnet, unifying its proven track in technological and management capabilities with companies in Spain and Portugal. The company is managed by a multi-task professional team with international experience. With proven clinical and scientific results, differentiated technology with enormous potential for future technological and financial capacity, intellectual property and developing lines, ONCOVISION is today ahead in the Spanish and European Health Industry.

KDPOF is a Madrid-based company specializing in high-capacity communication technology using Large Core Plastic Optical Fiber (POF). The company develops advanced systems that include digital integrated circuits designed for robust optical networking, particularly suited for harsh environments and long-reach communications. KDPOF's products are characterized by their inherent galvanic isolation, lightweight design, and cost-effectiveness. These features enable home and small office/home office (SOHO) networks, as well as clients in the automotive and industrial sectors, to achieve optical gigabit connectivity tailored to their specific needs. Through its innovative approach, KDPOF aims to enhance the efficiency and adaptability of POF communication technology, leveraging the latest advancements in digital communications and information theory.

KDPOF is a Madrid-based company specializing in high-capacity communication technology using Large Core Plastic Optical Fiber (POF). The company develops advanced systems that include digital integrated circuits designed for robust optical networking, particularly suited for harsh environments and long-reach communications. KDPOF's products are characterized by their inherent galvanic isolation, lightweight design, and cost-effectiveness. These features enable home and small office/home office (SOHO) networks, as well as clients in the automotive and industrial sectors, to achieve optical gigabit connectivity tailored to their specific needs. Through its innovative approach, KDPOF aims to enhance the efficiency and adaptability of POF communication technology, leveraging the latest advancements in digital communications and information theory.

Oncovision (GEM Imaging S.A.) is a Spanish technologic start-up company created in 2003 with the initiative of the Corpuscular Physics Institute (CSIC) and the University of Valencia. They work in Molecular Vision applied to Health Sciences focusing in: cancer diagnosis and treatment, and advanced research in neurology, oncology, and cardiology. They are a company focused on Molecular Vision, which creates, develops and markets new medical technologies, global innovations with relevant clinical and economic advantages, often representing a breakthrough in current standards of diagnosis and treatment. ONCOVISION´s original, fresh technology, strong intellectual property, top-level clinical evidence, leading global reference centers, and pioneering protocols, is supported by its dynamic cross-functional team. ONCOVISION is opening unprecedented options in the treatment of cancer and serious cardiac and neurological diseases. Their team and the company’s technologies have been recognized by Spanish and European prestigious institutions. In 2007, the company was selected as one of the “20 Best Technologic Companies in Spain” and won the “National Medical Physics 2007 Congress Award” In 2008, it was one of the “20 Best Health Technology Companies in Europe” by the prestigious European Technology Tour, as well as finalist in the “National 25th Aniversary Enisa Award” Prof. Jose María Benlloch, active member of the company, won in 2008, the well-known “Jaime I” award. Scientists, technicians, and technologists of ONCOVISION have dozens of publications and presentations at scientific and medical conferences worldwide. Their shareholding, based in Valencia, was strengthened in August 2006 by the Spanish venture capital firm Bullnet, unifying its proven track in technological and management capabilities with companies in Spain and Portugal. The company is managed by a multi-task professional team with international experience. With proven clinical and scientific results, differentiated technology with enormous potential for future technological and financial capacity, intellectual property and developing lines, ONCOVISION is today ahead in the Spanish and European Health Industry.

Netspira Networks develops software tools and applications for the management of added-value services in the data networks of mobile telephone operators. Founded in 2001, it is based in Madrid, Spain.